Published in Curr Oncol on July 01, 2010
Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer. Curr Oncol (2011) 0.89
KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis. Ont Health Technol Assess Ser (2010) 0.87
Drug therapy of cancer. Eur J Clin Pharmacol (2011) 0.83
Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes. Int J Otolaryngol (2013) 0.82
A novel fully automated molecular diagnostic system (AMDS) for colorectal cancer mutation detection. PLoS One (2013) 0.79
Benefits, issues, and recommendations for personalized medicine in oncology in Canada. Curr Oncol (2013) 0.78
BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies. J Gastrointest Oncol (2015) 0.78
KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis. J Exp Clin Cancer Res (2015) 0.77
Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab. Cancer Biol Ther (2013) 0.76
KRAS and BRAF Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer? Gastroenterol Res Pract (2015) 0.76
Novel Approach for Clinical Validation of the cobas KRAS Mutation Test in Advanced Colorectal Cancer. Mol Diagn Ther (2016) 0.76
Detection of K-ras Mutations in Predicting Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR-TK) Inhibitor in Patients with Metastatic Colorectal Cancer. PLoS One (2015) 0.75
KRAS mutation status is highly homogeneous between areas of the primary tumor and the corresponding metastasis of colorectal adenocarcinomas: one less problem in patient care. Am J Cancer Res (2017) 0.75
K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med (2008) 27.35
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol (2008) 20.89
Cetuximab for the treatment of colorectal cancer. N Engl J Med (2007) 13.39
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol (2008) 11.73
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol (2008) 10.29
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol (2008) 9.98
The use of synthetic oligonucleotides as hybridization probes. II. Hybridization of oligonucleotides of mixed sequence to rabbit beta-globin DNA. Nucleic Acids Res (1981) 9.56
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Oncol (2007) 9.29
Detection of sickle cell beta S-globin allele by hybridization with synthetic oligonucleotides. Proc Natl Acad Sci U S A (1983) 7.52
The price tag on progress--chemotherapy for colorectal cancer. N Engl J Med (2004) 6.43
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab. Ann Oncol (2007) 5.68
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies. Cancer Res (2007) 5.54
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. Br J Cancer (2007) 5.38
A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol (1999) 4.43
Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes. Clin Chem (2003) 2.91
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer. J Clin Oncol (2008) 2.57
KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection. J Clin Oncol (2009) 2.36
Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res (1991) 2.30
The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer. Arch Pathol Lab Med (2009) 1.56
EGFR and K-ras mutation analysis in non-small cell lung cancer: comparison of paraffin embedded versus frozen specimens. Cell Oncol (2007) 1.48
Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int J Cancer (1991) 1.47
Methods for detection of point mutations: performance and quality assessment. IFCC Scientific Division, Committee on Molecular Biology Techniques. Clin Chem (1997) 1.46
Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol (1998) 1.41
Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer. J Clin Oncol (2001) 1.09
K-ras point mutations in human colorectal carcinomas: relation to aneuploidy and metastasis. Int J Cancer (1992) 1.09
Methods of molecular analysis: mutation detection in solid tumours. Mol Pathol (2002) 0.96
Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ (1997) 5.02
ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res (2001) 4.47
The complete primary structure of protein kinase C--the major phorbol ester receptor. Science (1986) 4.02
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation (1996) 4.01
Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis (1980) 3.53
Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis (2000) 3.44
A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem (1982) 3.04
HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proc Natl Acad Sci U S A (2000) 3.00
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet (2004) 2.95
Possible new method to improve detection of diabetic retinopathy: Polaroid non-mydriatic retinal photography. Br Med J (Clin Res Ed) (1985) 2.83
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol (2011) 2.78
Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet (1990) 2.72
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas. Br J Cancer (2006) 2.23
Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res (1998) 2.20
Public health aspects of viral haemorrhagic fevers in Britain. R Soc Health J (1978) 2.18
Spongiform encephalopathy of Rocky Mountain elk. J Wildl Dis (1982) 2.11
Isolated microscopic haematuria in the genitourinary clinic: the value of renal biopsy. Int J STD AIDS (1997) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Restrict genetic susceptibility tests. Nature (1998) 1.99
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer (2010) 1.99
Tissue-specific expression of the alternative oxidase in soybean and siratro. Plant Physiol (1992) 1.94
Spongiform encephalopathies in Cervidae. Rev Sci Tech (1992) 1.92
The reliability of telephone interviews compared with in-person interviews using memory aids. Ann Epidemiol (2003) 1.86
TAZ is a novel oncogene in non-small cell lung cancer. Oncogene (2011) 1.85
Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm. Proc Natl Acad Sci U S A (2006) 1.80
Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum (1998) 1.79
v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell (1986) 1.76
Relationship between tumor grade and computed architectural complexity in breast cancer specimens. Hum Pathol (2008) 1.74
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma. Oncogene (2010) 1.73
Thoracic lymphangioma in adults: CT and MR imaging features. AJR Am J Roentgenol (1994) 1.72
Speed of onset of 'corner pocket supraclavicular' and infraclavicular ultrasound guided brachial plexus block: a randomised observer-blinded comparison. Anaesthesia (2009) 1.71
Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J Clin Microbiol (2004) 1.71
Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol (1993) 1.70
Enhanced urinalysis as a screening test for urinary tract infection. Pediatrics (1993) 1.68
Non-mydriatic Polaroid photography in screening for diabetic retinopathy: evaluation in a clinical setting. Br Med J (Clin Res Ed) (1988) 1.60
A case of Lassa fever: experience at St Thomas's Hospital. Br Med J (Clin Res Ed) (1982) 1.59
Randomized trial of two physiotherapy interventions for primary care neck and back pain patients: 'McKenzie' vs brief physiotherapy pain management. Rheumatology (Oxford) (2006) 1.55
Multilaboratory comparison of hepatitis C virus viral load assays. J Clin Microbiol (2006) 1.53
The association of age and semen quality in healthy men. Hum Reprod (2003) 1.52
Bronchial responsiveness and lung function in recurrently wheezy infants. Am Rev Respir Dis (1991) 1.51
The need for three stool specimens in routine laboratory examinations for intestinal parasites. Br J Clin Pract (1993) 1.50
Epidemiological aspects of Crohn's disease in Clydesdale 1961-1970. Gut (1975) 1.49
A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). Blood (1991) 1.47
Ocular lesions of bovine malignant catarrhal fever. Vet Pathol (1985) 1.47
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2006) 1.46
Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br J Cancer (2006) 1.44
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53. EMBO Mol Med (2012) 1.44
[The chemical working environment among car painters in Bergen]. Tidsskr Nor Laegeforen (1994) 1.39
Experience with the multiple-choice paper in the Primary Fellowship Examination in Glasgow: phase IV of an educational study. Br J Med Educ (1973) 1.39
Absorbable, delayed-release antibiotic beads reduce surgical wound infection. Am Surg (1997) 1.38
Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet (2004) 1.38
Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nat Genet (1997) 1.34
Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia (2007) 1.34
Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Clin Cancer Res (2001) 1.33
An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Neuroimage (2009) 1.32
Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol (2006) 1.31
Neuropathology of chronic wasting disease of mule deer (Odocoileus hemionus) and elk (Cervus elaphus nelsoni). Vet Pathol (1993) 1.31
Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol (1997) 1.31
Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem (1996) 1.29
Haemophilus somnus agglutinins in cattle. J Am Vet Med Assoc (1973) 1.28
Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet (2007) 1.28
The effects of male age on sperm DNA damage in healthy non-smokers. Hum Reprod (2006) 1.27
Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life. World J Surg (1998) 1.27
PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy. Gynecol Oncol (2012) 1.27
Detection of occult low-grade b-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology (1999) 1.26
Patient removals. Sitting pretty. Health Serv J (2000) 1.25
Quantitation of protein kinase C by immunoblot--expression in different cell lines and response to phorbol esters. J Cell Physiol (1987) 1.25
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol (2008) 1.24
Population-based study of pseudoprogression after chemoradiotherapy in GBM. Can J Neurol Sci (2009) 1.24
Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol (1997) 1.23
Prolapse of a cervical disc in elderly patients with cervical spondylosis. Br Med J (Clin Res Ed) (1986) 1.22
Improved COBAS TaqMan hepatitis C virus test (Version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite study. J Clin Microbiol (2007) 1.22
Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms. Clin Pharmacol Ther (2009) 1.21
Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.20
Quantifying the architectural complexity of microscopic images of histology specimens. Micron (2008) 1.19
Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood (1992) 1.19
Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol (2003) 1.17
Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic. Cancer Res (2010) 1.16
A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer (2003) 1.15
Vascular endothelial growth factor in human periodontal disease. J Periodontal Res (1998) 1.14
Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant. Blood (2001) 1.14
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. Br J Cancer (2012) 1.13
The effect of acute hyperglycaemia on the retinal circulation of the normal cat. Diabetologia (1980) 1.13
Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease. J Neuropathol Exp Neurol (1992) 1.13
P63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol (2004) 1.13
Observation of high-energy neutrinos using Cerenkov detectors embedded deep in Antarctic ice. Nature (2001) 1.12
Analogous pleiotropic effects of insecticide resistance genotypes in peach-potato aphids and houseflies. Heredity (Edinb) (2003) 1.12
Clinical and pathological findings in dogs following supralethal total body irradiation with and without infusion of autologous long-term marrow culture cells. Can J Vet Res (1993) 1.11
Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med (2001) 1.10
Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor. J Biol Chem (1984) 1.10
Results of surgery for Crohn's disease in the Glasgow region, 1961-70. Br J Surg (1975) 1.10
Rapid detection of Gram-positive organisms by use of the Verigene Gram-positive blood culture nucleic acid test and the BacT/Alert Pediatric FAN system in a multicenter pediatric evaluation. J Clin Microbiol (2013) 1.09
Diversion of retinal blood flow by photocoagulation. Br J Ophthalmol (1978) 1.08
Postoperative pneumonia: a prospective study of risk factors and morbidity. Surgery (1993) 1.08
The structural gene for cytochrome c551 from Pseudomonas aeruginosa. The nucleotide sequence shows a location downstream of the nitrite reductase gene. FEBS Lett (1990) 1.07
Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival. J Transl Med (2010) 1.07
Training in molecular cytopathology. Cytopathology (2013) 1.06